Avesthagen IP model achieves valuation of Euro 115mn

RELATED NEWS Avesthagen advances in Salt Tolerance Program Villoo M Patell receives Entrepreneur of the Year 2006 Nifty BSE | NSE 29/05/12 Are Mutual Funds betting on Nifty?

Going forward, Avesthagen' activities are being re-organized into four strategic business units including bio-pharmaceuticals, bio-nutritionals agri-biotech, science & innovation. Each of these units will be run as independent profit centers with dedicated management teams. Avesthagen's immediate focus will be intensifying its IP through product commercialisation.

 

Avesthagen has started preparations for its IPO which is scheduled to take place by mid 2008, around which time the commercial launch of the first products is expected for the bio-nutritional and bio-pharmaceutical product pipelines. The headcount of the Company is anticipated to increase to over 600 within the 18 months

 

Standing at the dawn of a new cycle of expansion and science & technology driven growth, Avesthagen is also pleased to present its new corporate identity and logo. The new identity for the Avesthagen group embodies the organization's commitment to evolve new solutions and creative ideas.

  

Sourced From: LINOpinion - The Lintas Public Relations Division